Dexcom G7 CGM
Type 1 and Type 2 Diabetes
CommercialActive
Key Facts
About Dexcom
Dexcom has established itself as the market leader in continuous glucose monitoring technology over 25 years, transforming diabetes care with real-time glucose tracking that eliminates the need for fingerstick testing. The company's flagship Dexcom G7 system represents the most accurate CGM technology available, while their new Stelo biosensor expands their addressable market to people without diabetes seeking metabolic health insights. With a strong commercial presence and robust innovation pipeline, Dexcom continues to set the standard in glucose biosensing technology.
View full company profileTherapeutic Areas
Other Type 1 and Type 2 Diabetes Drugs
| Drug | Company | Phase |
|---|---|---|
| Dexcom G7 15 Day | Dexcom | Commercial |